Schering-Plough

The U.S. Justice Department accused the company of lying to the government about drug prices and improperly marketing cancer drugs for uses not approved by the Food and Drug Administration. According to the government, Schering-Plough engaged in illegal sales and marketing programs for several cancer drugs. It improperly promoted Temodar for use in brain tumors and metastatic cancer, and pushed the drug Intron A for use in superficial bladder cancer and hepatitis C. Schering-Plough has agreed to pay $435 million in fines and has pleaded guilty to criminal conspiracy charges. (Aug-30-06) [INTERNATIONAL HERALD TRIBUNE]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.